• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发展适用于群组随机试验成本效益分析的方法。

Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials.

机构信息

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK (MG, ESWN, RG)

Modeling and Simulation Group, Novartis Pharma AG, Basel, Switzerland (RN)

出版信息

Med Decis Making. 2012 Mar-Apr;32(2):350-61. doi: 10.1177/0272989X11418372. Epub 2011 Oct 19.

DOI:10.1177/0272989X11418372
PMID:22016450
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3757919/
Abstract

AIM

Cost-effectiveness analyses (CEAs) may use data from cluster randomized trials (CRTs), where the unit of randomization is the cluster, not the individual. However, most studies use analytical methods that ignore clustering. This article compares alternative statistical methods for accommodating clustering in CEAs of CRTs.

METHODS

Our simulation study compared the performance of statistical methods for CEAs of CRTs with 2 treatment arms. The study considered a method that ignored clustering--seemingly unrelated regression (SUR) without a robust standard error (SE)--and 4 methods that recognized clustering--SUR and generalized estimating equations (GEEs), both with robust SE, a "2-stage" nonparametric bootstrap (TSB) with shrinkage correction, and a multilevel model (MLM). The base case assumed CRTs with moderate numbers of balanced clusters (20 per arm) and normally distributed costs. Other scenarios included CRTs with few clusters, imbalanced cluster sizes, and skewed costs. Performance was reported as bias, root mean squared error (rMSE), and confidence interval (CI) coverage for estimating incremental net benefits (INBs). We also compared the methods in a case study.

RESULTS

Each method reported low levels of bias. Without the robust SE, SUR gave poor CI coverage (base case: 0.89 v. nominal level: 0.95). The MLM and TSB performed well in each scenario (CI coverage, 0.92-0.95). With few clusters, the GEE and SUR (with robust SE) had coverage below 0.90. In the case study, the mean INBs were similar across all methods, but ignoring clustering underestimated statistical uncertainty and the value of further research.

CONCLUSIONS

MLMs and the TSB are appropriate analytical methods for CEAs of CRTs with the characteristics described. SUR and GEE are not recommended for studies with few clusters.

摘要

目的

成本效益分析(CEA)可以使用来自整群随机试验(CRT)的数据,其中随机化的单位是群组,而不是个体。然而,大多数研究使用忽略聚类的分析方法。本文比较了 CRT 的 CEA 中用于容纳聚类的替代统计方法。

方法

我们的模拟研究比较了具有 2 种治疗臂的 CRT 的 CEA 的统计方法的性能。该研究考虑了一种忽略聚类的方法 - 看似不相关回归(SUR)而没有稳健标准误差(SE) - 以及 4 种认识聚类的方法 - SUR 和广义估计方程(GEE),两者均具有稳健 SE、带有收缩校正的“2 阶段”非参数引导(TSB)和多层次模型(MLM)。基本情况假设 CRT 具有中等数量的平衡群组(每臂 20 个)和正态分布的成本。其他情况包括具有较少群组、不平衡群组大小和偏态成本的 CRT。性能以估计增量净效益(INB)的偏差、均方根误差(rMSE)和置信区间(CI)覆盖率报告。我们还在案例研究中比较了这些方法。

结果

每种方法报告的偏差水平都较低。没有稳健 SE,SUR 的 CI 覆盖率较差(基本情况:0.89 与名义水平:0.95)。MLM 和 TSB 在每种情况下表现良好(CI 覆盖率,0.92-0.95)。群组较少时,GEE 和 SUR(带稳健 SE)的覆盖率低于 0.90。在案例研究中,所有方法的平均 INB 相似,但忽略聚类会低估统计不确定性和进一步研究的价值。

结论

MLM 和 TSB 是描述特征的 CRT 的 CEA 的适当分析方法。对于群组较少的研究,不建议使用 SUR 和 GEE。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f804/3757919/cea84695dc34/10.1177_0272989X11418372-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f804/3757919/cea84695dc34/10.1177_0272989X11418372-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f804/3757919/cea84695dc34/10.1177_0272989X11418372-fig1.jpg

相似文献

1
Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials.发展适用于群组随机试验成本效益分析的方法。
Med Decis Making. 2012 Mar-Apr;32(2):350-61. doi: 10.1177/0272989X11418372. Epub 2011 Oct 19.
2
Methods for covariate adjustment in cost-effectiveness analysis that use cluster randomised trials.在成本效益分析中使用整群随机试验进行协变量调整的方法。
Health Econ. 2012 Sep;21(9):1101-18. doi: 10.1002/hec.2812. Epub 2012 Mar 28.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Multiple imputation methods for handling missing data in cost-effectiveness analyses that use data from hierarchical studies: an application to cluster randomized trials.多变量填补方法在使用来自层级研究数据的成本效益分析中处理缺失数据:一项对整群随机试验的应用。
Med Decis Making. 2013 Nov;33(8):1051-63. doi: 10.1177/0272989X13492203. Epub 2013 Aug 1.
5
Statistical methods for cost-effectiveness analyses that use data from cluster randomized trials: a systematic review and checklist for critical appraisal.用于成本效益分析的来自于群组随机试验的数据的统计方法:系统评价和关键评估清单。
Med Decis Making. 2012 Jan-Feb;32(1):209-20. doi: 10.1177/0272989X11407341. Epub 2011 May 24.
6
Comparison of population-averaged and cluster-specific models for the analysis of cluster randomized trials with missing binary outcomes: a simulation study.比较群体平均模型和聚类特异性模型在分析缺失二分类结局的整群随机试验中的应用:一项模拟研究。
BMC Med Res Methodol. 2013 Jan 23;13:9. doi: 10.1186/1471-2288-13-9.
7
Warnings on the inclusion of cluster randomized trials in meta-analysis: results of a simulation study.关于在荟萃分析中纳入整群随机试验的警告:一项模拟研究的结果
BMC Med Res Methodol. 2025 May 15;25(1):133. doi: 10.1186/s12874-025-02586-2.
8
Increased risk of type I errors in cluster randomised trials with small or medium numbers of clusters: a review, reanalysis, and simulation study.小型或中型整群随机试验中I型错误风险增加:一项综述、再分析及模拟研究
Trials. 2016 Sep 6;17(1):438. doi: 10.1186/s13063-016-1571-2.
9
Small sample performance of bias-corrected sandwich estimators for cluster-randomized trials with binary outcomes.具有二元结局的整群随机试验的偏差校正三明治估计量的小样本性能。
Stat Med. 2015 Jan 30;34(2):281-96. doi: 10.1002/sim.6344. Epub 2014 Oct 24.
10
Taking the Analysis of Trial-Based Economic Evaluations to the Next Level: The Importance of Accounting for Clustering.将基于试验的经济评估分析提升到一个新的水平:考虑聚类的重要性。
Pharmacoeconomics. 2020 Nov;38(11):1247-1261. doi: 10.1007/s40273-020-00946-y.

引用本文的文献

1
Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial): a randomised controlled trial protocol.胃肠胰神经内分泌肿瘤患者病情进展后生长抑素类似物的持续使用(SAUNA试验):一项随机对照试验方案
BMJ Open. 2025 Jul 3;15(7):e099996. doi: 10.1136/bmjopen-2025-099996.
2
Implementing remote patient monitoring to improve hypertension control in a primary care network: Rationale and design of the monitor-BP Cluster Randomized Trial.在初级保健网络中实施远程患者监测以改善高血压控制:Monitor-BP 整群随机试验的原理与设计
Am Heart J. 2025 Oct;288:52-64. doi: 10.1016/j.ahj.2025.04.005. Epub 2025 Apr 8.
3

本文引用的文献

1
Statistical methods for cost-effectiveness analyses that use data from cluster randomized trials: a systematic review and checklist for critical appraisal.用于成本效益分析的来自于群组随机试验的数据的统计方法:系统评价和关键评估清单。
Med Decis Making. 2012 Jan-Feb;32(1):209-20. doi: 10.1177/0272989X11407341. Epub 2011 May 24.
2
A comparison of the statistical power of different methods for the analysis of repeated cross-sectional cluster randomization trials with binary outcomes.对不同方法分析具有二元结局的重复横断面整群随机试验的统计效能进行比较。
Int J Biostat. 2010 Mar 29;6(1):Article 11. doi: 10.2202/1557-4679.1179.
3
Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT.
醛固酮受体拮抗剂在慢性肾脏病中的益处:BARACK-D随机对照试验
Health Technol Assess. 2025 Mar;29(5):1-130. doi: 10.3310/PYFT6977.
4
Cost effectiveness of a GP delivered medication review to reduce polypharmacy and potentially inappropriate prescribing in older patients with multimorbidity in Irish primary care: the SPPiRE cluster randomised controlled trial.在爱尔兰初级医疗中,全科医生开展药物评估以减少老年多病患者的多重用药及潜在不适当处方的成本效益:SPPiRE 整群随机对照试验
Eur J Health Econ. 2025 Apr;26(3):427-454. doi: 10.1007/s10198-024-01718-7. Epub 2024 Aug 27.
5
The performance of a Bayesian value-based sequential clinical trial design in the presence of an equivocal cost-effectiveness signal: evidence from the HERO trial.存在不确定成本效益信号时基于价值的贝叶斯序贯临床试验设计的性能:来自 HERO 试验的证据。
BMC Med Res Methodol. 2024 Jul 19;24(1):155. doi: 10.1186/s12874-024-02248-9.
6
A study protocol for a cluster-randomised controlled trial of smartphone-activated first responders with ultraportable defibrillators in out-of-hospital cardiac arrest: The First Responder Shock Trial (FIRST).一项关于在院外心脏骤停中使用超便携除颤器的智能手机激活第一响应者的整群随机对照试验的研究方案:第一响应者电击试验(FIRST)。
Resusc Plus. 2023 Sep 6;16:100466. doi: 10.1016/j.resplu.2023.100466. eCollection 2023 Dec.
7
Conducting Trial-Based Economic Evaluations Using R: A Tutorial.使用R进行基于试验的经济评估:教程
Pharmacoeconomics. 2023 Nov;41(11):1403-1413. doi: 10.1007/s40273-023-01301-7. Epub 2023 Jul 17.
8
A single-blind, parallel-group randomised trial of a Technology-assisted and remotely delivered Cognitive Behavioural Therapy intervention (Tech-CBT) versus usual care to reduce anxiety in people with mild cognitive impairment and dementia: study protocol for a randomised trial.一项针对轻度认知障碍和痴呆患者的焦虑的技术辅助和远程提供的认知行为疗法干预(Tech-CBT)与常规护理的单盲、平行组随机试验:一项随机试验的研究方案。
Trials. 2023 Jun 20;24(1):420. doi: 10.1186/s13063-023-07381-2.
9
Cost-effectiveness of peer-supported self-management for people discharged from a mental health crisis team: methodological challenges and recommendations.同伴支持的自我管理对从心理健康危机团队出院人员的成本效益:方法学挑战与建议
Front Psychiatry. 2023 Jun 2;14:1031159. doi: 10.3389/fpsyt.2023.1031159. eCollection 2023.
10
Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trial.评估差异化护理数字依从技术对支持埃塞俄比亚结核病治疗依从性的公平影响和成本效益:一项集群随机试验健康经济学部分的方案和分析计划。
Trials. 2023 Apr 24;24(1):292. doi: 10.1186/s13063-023-07289-x.
Joint generalized estimating equations for multivariate longitudinal binary outcomes with missing data: An application to AIDS data.
具有缺失数据的多元纵向二元结局的联合广义估计方程:在艾滋病数据中的应用
J R Stat Soc Ser A Stat Soc. 2009 Jan;172(1):3-20. doi: 10.1111/j.1467-985X.2008.00564.x.
4
Statistical analysis of cost-effectiveness data from randomized clinical trials.随机临床试验成本效益数据的统计分析。
Expert Rev Pharmacoecon Outcomes Res. 2006 Jun;6(3):337-46. doi: 10.1586/14737167.6.3.337.
5
Dangerous omissions: the consequences of ignoring decision uncertainty.危险的疏忽:忽视决策不确定性的后果。
Health Econ. 2011 Feb;20(2):212-24. doi: 10.1002/hec.1586.
6
Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial.定制化实践与患者护理计划对全科医疗中冠心病二级预防的影响:整群随机对照试验
BMJ. 2009 Oct 29;339:b4220. doi: 10.1136/bmj.b4220.
7
Bayesian hierarchical models for cost-effectiveness analyses that use data from cluster randomized trials.贝叶斯层次模型在使用来自整群随机试验数据的成本效益分析中的应用。
Med Decis Making. 2010 Mar-Apr;30(2):163-75. doi: 10.1177/0272989X09341752. Epub 2009 Aug 12.
8
Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared.非参数法在成本效益分析中的应用:中心极限定理与自助法的比较。
Health Econ. 2010 Mar;19(3):316-33. doi: 10.1002/hec.1477.
9
Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care.健康访视员产后抑郁心理知情干预培训的临床效果:基层医疗中的实用整群随机试验
BMJ. 2009 Jan 15;338:a3045. doi: 10.1136/bmj.a3045.
10
Effects of algorithm for diagnosis of active labour: cluster randomised trial.活跃产程诊断算法的效果:整群随机试验
BMJ. 2008 Dec 8;337:a2396. doi: 10.1136/bmj.a2396.